Mesa Laboratories Inc. (MLAB) Director H Stuart Campbell Sells 3,000 Shares
Mesa Laboratories Inc. (NASDAQ:MLAB) Director H Stuart Campbell sold 3,000 shares of Mesa Laboratories stock in a transaction dated Friday, September 16th. The shares were sold at an average price of $115.03, for a total value of $345,090.00. Following the transaction, the director now owns 67,930 shares of the company’s stock, valued at approximately $7,813,987.90. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Mesa Laboratories Inc. (NASDAQ:MLAB) opened at 121.48 on Thursday. The stock has a market cap of $445.22 million, a P/E ratio of 44.35 and a beta of 0.66. The stock has a 50 day moving average price of $114.50 and a 200-day moving average price of $110.86. Mesa Laboratories Inc. has a 52 week low of $77.00 and a 52 week high of $131.88.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 15th. Shareholders of record on Wednesday, November 30th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.53%. The ex-dividend date of this dividend is Monday, November 28th. Mesa Laboratories’s dividend payout ratio is 23.97%.
Separately, Zacks Investment Research downgraded Mesa Laboratories from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 10th.
Mesa Laboratories Company Profile
Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.
Receive News & Stock Ratings for Mesa Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories Inc. and related stocks with our FREE daily email newsletter.